The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the ...

Under direction of Health Secretary Robert F. Kennedy Jr., the CDC is considering changes to its recommendations on vaccines ...

Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...

A new study to boost the number of expectant mothers having the Respiratory Syncytial Virus (RSV) immunisation and ...

Respiratory syncytial virus (RSV) is a leading cause of hospitalization and mortality in children under six years old. With millions of cases annually worldwide, especially among infants under six ...

The CDC's Advisory Committee on Immunization Practices (ACIP) voted 14-0, with one abstention, on Wednesday to recommend that ...

Full results from the trial were published in The Lancet Child & Adolescent Health. 1 "This pivotal Phase III trial provides the first solid evidence of an effective antiviral treatment for RSV in ...

The Centers for Disease Control and Prevention (CDC) has recently updated its vaccine recommendations for three critical diseases: meningococcal, respiratory syncytial virus (RSV), and chikungunya.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices voted to expand access to ...

RSV, a common virus that triggers lung infections ... this seems largely due to increased testing, particularly in children and in older and vulnerable populations. There are currently three ...